Searchable abstracts of presentations at key conferences in endocrinology

ea0090p390 | Endocrine-related Cancer | ECE2023

Efficacity of combination of Lenvatinib and PPRT in severe hypersecretion of VIP

Raluca Mitru Natalia , Hadoux Julien , Lamartina Livia , Pani Fabiana , Baudin Eric , Moog Sophie

Introduction: VIPomas are rare neuroendocrine tumors (NET), usually located in the pancreas that secrete vasoactive intestinal polypeptide (VIP) leading to high-volume watery diarrhea and complications such as hypokalemia, acidosis and dehydration. The management of VIPoma symptoms is often challenging when surgical resection of all the lesions is not feasible. Treatments are then based on somatostatin analogs (SSA) and may also include hepatic chemoembolization, systemic chem...

ea0090p651 | Endocrine-related Cancer | ECE2023

Impact of vascular invasion on otherwise low-risk papillary thyroid carcinomas: a retrospective and observational study

Marques Puga Francisca , Al Ghuzlan Abir , Hartl Dana M. , Bani Mohamed-Amine , Moog Sophie , Pani Fabiana , Breuskin Ingrid , Guerlain Joanne , Faron Matthieu , Denadreis Desiree , Baudin Eric , Hadoux Julien , Lamartina Livia

Background: Presence of venous vascular invasion is a criterion of intermediate risk of recurrence in papillary thyroid carcinoma (PTC). However, the presence and type of vascular invasion (lymphatic or venous) is often underreported and its impact on PTCs without other risk features remains unknown.Objective: To evaluate the impact of both lymphatic and venous invasion on the risk of recurrence/persistence on otherwise low-risk PTCs. <p class="abste...

ea0092ps2-17-06 | Thyroid Cancer Diagnosis 2 | ETA2023

Impact of lymphovascular invasion on otherwise low-risk papillary thyroid carcinomas: A retrospective and observational study

Puga Francisca , Al Ghuzlan Abir , Hartl Dana M. , Bani Mohamed-Amine , Moog Sophie , Pani Fabiana , Breuskin Ingrid , Guerlain Joanne , Faron Matthieu , Denadreis Desiree , Baudin Eric , Hadoux Julien , Lamartina Livia

Background: Presence of venous vascular invasion is a criterion of intermediate risk of recurrence in papillary thyroid carcinoma (PTC). However, the presence and type of vascular invasion (lymphatic or venous) is often underreported and its impact on PTCs without other risk features remains unknown.Objective: To evaluate the impact of both lymphatic and venous invasion on the risk of recurrence/persistence on otherwise low-risk PTCs.<p class="abstex...